Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 3, 2002, Pages 285-294

  Yumoto, Eiichiro ^a,b   Higashi, Toshihiro ^c   Nouso, Kazuhiro ^a   Nakatsukasa, Harushige ^a   Fujiwara, Keishi ^a   Hanafusa, Tadashi ^d   Yumoto, Yasuhiro ^d   Tanimoto, Tadao ^e   Kurimoto, Masashi ^e   Tanaka, Noriaki ^a,b   Tsuji, Takao ^a  

^a Second Dept of Internal Medicine   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Okayama Citizens Hospital   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Fulminant hepatic failure; IFN ; IL 10; IL 18; Prognosis

Indexed keywords

BILIRUBIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4;

ACUTE HEPATITIS; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HELPER CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INTENSIVE CARE UNIT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VIRUS HEPATITIS; VOLUNTEER;

EID: 0036097454     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02690.x     Document Type: Article

References (46)

1. Hepatitis B virus immunopathogenesis
2. Hepatitis C virus-specific responses in the liver of chimpanzees with acute and chronic hepatitis C
3. T cell mechanisms in the immunopathogenesis of viral hepatitis B and C
4. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
5. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
6. Viral cross talk. Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
7. Mechanisms of liver damage
8. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice
9. Pathogenesis effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice
10. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure
11. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histo-compatibility complex class II negative tumors
12. B cells inhibit induction of T-cell dependent tumor immunity
13. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins
14. TH1 and TH2 cells; different patterns of lymphokine secretion lead to different functional properties
15. Restricted T cell expression of IL-2/IFN-γ mRNA in human inflammatory disease
16. Cloning of a new cytokine that induces IFN-gamma production by T cells
17. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells
18. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones
19. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
20. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones
21. Natural killer cell stimulatory factor (Interleukin 12 ) induces T helper type (Th1) -specific immune responses and inhibits the development of IL-4 producing Th cells
22. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study
23. Early indicators of prognosis in fulminant hepatic failure
24. National investigation for fulminant hepatic failure in 1993. The research report of 1993 Intractable Hepatitis Committee
25. Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis
26. Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ('interleukin-18') in mouse intestinal epithelial cells
27. Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance
28. Failure to detect circulating interferon during acute viral hepatitis
29. Absence of detectable serum interferon in acute and chronic viral hepatitis
30. Serum level of interferon-α and -γ in acute and chronic hepatitis B virus infection
31. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL) -12 and IL-18: A novel pathway of autocrine macrophage activation
32. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis
33. Demonstration of a cellular immune response in halothane-exposed guinea pig
34. Interaction of lymphocytes with Kupffer cells from halothane-exposed guinea pigs
35. Role of Kupffer cells in rat liver injury induced by diethyldithiocarbamate
36. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production
37. Immune complexes in hepatitis
38. Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B
39. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapside-specific T cells in acute self-limited hepatitis B
40. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
41. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury
42. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis
43. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice
44. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors
45. Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis
46. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice